{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:14:55Z","timestamp":1780416895879,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF2013-02355704"],"award-info":[{"award-number":["RF2013-02355704"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.nbd.2020.105157","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T12:38:27Z","timestamp":1603888707000},"page":"105157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine"],"prefix":"10.1016","volume":"147","author":[{"given":"Rosaria","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Demartini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Zanaboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Casini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"De Icco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Reggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Misto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.105157_bb0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/17460440903018857","article-title":"Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders","volume":"4","author":"Ahn","year":"2009","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.nbd.2020.105157_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.106.106971","article-title":"Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons","volume":"320","author":"Akerman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2020.105157_bb0015","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.jchromb.2009.01.008","article-title":"Lipidomic analysis of endocannabinoid metabolism in biological samples","volume":"877","author":"Astarita","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.nbd.2020.105157_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2007.03.071","article-title":"AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain","volume":"1152","author":"Borsani","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.105157_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/WCO.0000000000000437","article-title":"Extracranial origin of headache","volume":"30","author":"Burstein","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2020.105157_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0072-9752(10)97008-5","article-title":"Experimental models of migraine","volume":"97","author":"Buzzi","year":"2010","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2020.105157_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2014.06.046","article-title":"Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization","volume":"740","author":"Capuano","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105157_bb0040","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/CIRCRESAHA.110.216523","article-title":"Control of macrophage activation and function by PPARs","volume":"106","author":"Chawla","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.nbd.2020.105157_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fvets.2019.00377","article-title":"Corrigendum: cellular distribution of canonical and putative cannabinoid receptors in canine cervical dorsal root ganglia","volume":"6","author":"Chiocchetti","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.nbd.2020.105157_bb0050","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.105157_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2019.02.002","article-title":"Nitroglycerin as a comparative experimental model of migraine pain: from animal to human and back","volume":"177","author":"Demartini","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2020.105157_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2020.105157_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(96)00279-8","article-title":"123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors","volume":"307","author":"Gatley","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105157_bb0070","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuro.2005.02.005","article-title":"Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine","volume":"26","author":"Greco","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2020.105157_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10194-010-0274-4","article-title":"Effects of anandamide in migraine: data from an animal model. Version 2","volume":"12","author":"Greco","year":"2011","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.nbd.2020.105157_bb0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102414566862","article-title":"Effects of peripheral FAAH blockade on NTG-induced hyperalgesia\u2014evaluation of URB937 in an animal model of migraine","volume":"35","author":"Greco","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nbd.2020.105157_bb0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/s10194-015-0560-2","article-title":"Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine","volume":"16","author":"Greco","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.nbd.2020.105157_bb0090","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0333102416678000","article-title":"Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: targets and anti-migraine mechanisms","volume":"37","author":"Greco","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nbd.2020.105157_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fnins.2018.00172","article-title":"Endocannabinoid system and migraine pain: an update","volume":"12","author":"Greco","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2020.105157_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s10194-018-0879-6","article-title":"Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing","volume":"19","author":"Greco","year":"2018","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.nbd.2020.105157_bb0105","doi-asserted-by":"crossref","first-page":"104624","DOI":"10.1016\/j.nbd.2019.104624","article-title":"FAAH inhibition as a preventive treatment for migraine: a pre-clinical study","volume":"134","author":"Greco","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105157_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-019-1043-7","article-title":"Animal models of migraine and experimental techniques used to examine trigeminal sensory processing","volume":"20","author":"Harriott","year":"2019","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.nbd.2020.105157_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2020.105157_bb0120","first-page":"311","article-title":"Biological actions of drug solvents","volume":"113","author":"Kelava","year":"2011","journal-title":"Period. Biol."},{"key":"10.1016\/j.nbd.2020.105157_bb0125","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1124\/mol.105.015644","article-title":"Phosphorylation-dependent desensitization by anandamide of vanilloidreceptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1","volume":"69","author":"Lizanecz","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105157_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105157_bb0135","doi-asserted-by":"crossref","first-page":"116670","DOI":"10.1016\/j.lfs.2019.116670","article-title":"Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: a mechanistic study","volume":"232","author":"Mohammadi Vosough","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2020.105157_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.phrs.2011.07.001","article-title":"The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system","volume":"64","author":"Moreno-Sanz","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2020.105157_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2013.01.003","article-title":"Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction","volume":"138","author":"Panlilio","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2020.105157_bb0150","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/0024-3205(95)00175-6","article-title":"AM630, a competitive cannabinoid receptor antagonist","volume":"56","author":"Pertwee","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2020.105157_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn.3612","article-title":"Peripheral gating of pain signals by endogenous lipid mediators [published correction appears in Nat Neurosci 2014; 17: 1287]","volume":"17","author":"Piomelli","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.105157_bb0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/10409238.2015.1092944","article-title":"Macrophage-derived lipid agonists of PPAR-\u03b1 as intrinsic controllers of inflammation","volume":"51","author":"Pontis","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.nbd.2020.105157_bb0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","article-title":"Characterization of a novel model of chronic migraine","volume":"155","author":"Pradhan","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.nbd.2020.105157_bb0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(03)00333-6","article-title":"The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat","volume":"120","author":"Price","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2020.105157_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neubiorev.2003.12.003","article-title":"The orofacial formalin test","volume":"28","author":"Raboisson","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2020.105157_bb0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s13311-018-0622-7","article-title":"The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy","volume":"15","author":"Raffaelli","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2020.105157_bb0185","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1111\/bph.13980","article-title":"Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPAR\u03b1 and CB1 receptors","volume":"174","author":"Rock","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105157_bb0190","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.phrs.2012.02.012","article-title":"Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions","volume":"65","author":"Sasso","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2020.105157_bb0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/WCO.0000000000000688","article-title":"The endocannabinoid system in migraine: from bench to pharmacy and back","volume":"32","author":"Tassorelli","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2020.105157_bb0200","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2020.105157_bb0205","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/jphp.13166","article-title":"Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats","volume":"71","author":"Vozella","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105157_bb0210","doi-asserted-by":"crossref","first-page":"1700782","DOI":"10.1183\/13993003.00782-2017","article-title":"Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy","volume":"50","author":"Wortley","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.nbd.2020.105157_bb0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmerman","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.nbd.2020.105157_bb0220","doi-asserted-by":"crossref","first-page":"253","DOI":"10.55782\/ane-2015-2032","article-title":"Trigemino-hypoglossal somatic reflex in the pharmacological studies of nociception in orofacial area","volume":"75","author":"Zubrzycki","year":"2015","journal-title":"Acta Neurobiol. Exp. (Wars)"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120304320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120304320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:54:13Z","timestamp":1778576053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120304320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":44,"alternative-id":["S0969996120304320"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105157","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105157"}}